Enhanced RNA replication and pathogenesis in recent SARS-CoV-2 variants harboring the L260F mutation in NSP6
Authors:
Open Access
- 31 March 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 21 (3) , e1013020
Abstract
The COVID-19 pandemic has been driven by SARS-CoV-2 variants with enhanced transmission and immune escape. Apart from extensive evolution in the Spike protein, non-Spike mutations are accumulating across the entire viral genome and their functional impact is not well understood. To address the contribution of these mutations, we reconstructed genomes of recent Omicron variants with disabled Spike expression (replicons) to systematically compare their RNA replication capabilities independently from Spike. We also used a single reference replicon and complemented it with various Omicron variant Spike proteins to quantify viral entry capabilities in single-round infection assays. Viral entry and RNA replication were negatively correlated, suggesting that as variants evolve reduced entry functions under growing immune pressure on Spike, RNA replication increases as a compensatory mechanism. We identified multiple mutations across the viral genome that enhanced viral RNA replication. NSP6 emerged as a hotspot with a distinct L260F mutation independently arising in the BQ.1.1 and XBB.1.16 variants. Using mutant and revertant NSP6 viral clones, the L260F mutation was validated to enhance viral replication in cells and increase pathogenesis in mice. Notably, this mutation reduced host lipid droplet content by NSP6. Collectively, a systematic analysis of RNA replication of recent Omicron variants defined NSP6’s key role in viral RNA replication that provides insight into evolutionary trajectories of recent variants with possible therapeutic implications.Keywords
All Related Versions
Funding Information
- NIH (U19AI135990)
- NIH (U19AI135972)
- NIH (F31AI164671-01)
- Roddenberry Foundation
- P. and E. Taft
- Schmidt Sciences
- Gordon and Betty Moore Foundation
- James B. Pendleton Charitable Trust
- Chan Zuckerberg Biohub
This publication has 30 references indexed in Scilit:
- Enhanced immune evasion of SARS-CoV-2 variants KP.3.1.1 and XEC through N-terminal domain mutationsThe Lancet Infectious Diseases, 2024
- Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasioniScience, 2024
- Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionNature Communications, 2024
- Virological characteristics of the SARS-CoV-2 JN.1 variantThe Lancet Infectious Diseases, 2024
- Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressureThe Lancet Infectious Diseases, 2023
- SARS-CoV-2 variants with NSP12 P323L/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibilityCell Reports, 2023
- Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6Nature Communications, 2023
- The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expressionCell Reports, 2021
- Generation of Recombinant SARS‐CoV‐2 Using a Bacterial Artificial ChromosomeCurrent Protocols in Microbiology, 2020
- mTORC1 Phosphorylates UVRAG to Negatively Regulate Autophagosome and Endosome MaturationMolecular Cell, 2015